Skip to main content
Clinical Trials/NCT02078999
NCT02078999
Completed
N/A

Observational Study in Patients Admitted in the Intensive Care Unit.Tracheal Bacterial Load Surveillance in Patients Undergoing Mechanical Ventilation - Assessment of Biomarkers in the Distinction Between Colonization and Infection

Corporacion Parc Tauli1 site in 1 country211 target enrollmentSeptember 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Ventilator Associated Pneumonia
Sponsor
Corporacion Parc Tauli
Enrollment
211
Locations
1
Primary Endpoint
Procalcitonine (PCT) levels evolution
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

To evaluate in a cohort of patients on mechanical ventilation, for non-infectious reasons and for documented sepsis of pulmonary as well as non-pulmonary origin, the bacterial load, procalcitonine (PCT), C-Reactive Protein (CRP), temperature, White cell count (WCC), American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM) consensus conference criteria, Sequential Organ Failure Assessment score (SOFA) and simplified Clinical Pulmonary Infection Score (CPIS) through the mechanical ventilation period

Detailed Description

The investigators hypotized that: 1. In patients on mechanical ventilation for a non-infectious cause of respiratory failure, the tracheal bacterial load should be absent or below the cut-off values defined for infection, that is to say tracheal colonization. 2. In patients without the diagnosis of Ventilator-Adquired Pneumonia (VAP) and not taking antibiotics till the weaning process, tracheal bacterial load should remain below the predefined cut-off values and the biomarkers (PCT and CRP) should be surrogate markers of this clinical course. 3. In patients developing VAP, an increase in tracheal bacterial load should precede diagnosis with an associated rise in the biomarkers levels (PCT and CRP). Finally, after institution of antibiotic therapy, adequate therapy should be associated with a decrease tracheal bacterial load as well as of the biomarkers (PCT and CRP). 4. In patients admitted with clinical suspicion of pneumonia, either community-acquired (CAP) or hospital-acquired (HAP), with microbiological documentation, after institution of antibiotic therapy, adequate therapy should be associated with a decrease tracheal bacterial load as well as the biomarkers (PCT and CRP). 5. In patients admitted with clinical suspicion of a non-pulmonary infection (e.g. peritonitis and urosepsis) and on mechanical ventilation for an expected length longer than 3 days, either community or hospital-acquired, preferentially with microbiological documentation, after institution of antibiotic therapy, adequate therapy should be associated with a decrease of biomarkers (PCT and CRP).

Registry
clinicaltrials.gov
Start Date
September 2008
End Date
September 2015
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Corporacion Parc Tauli
Responsible Party
Principal Investigator
Principal Investigator

Antonio Artigas Raventós

PhD

Corporacion Parc Tauli

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients \<18 yrs old
  • Pregnancy and lactation
  • Fulminant hepatic failure
  • Pancreatitis
  • Patients with the diagnosis of disseminated cancer, expected to die or undergo withdrawal of treatment within 72 hours after enrolment.

Outcomes

Primary Outcomes

Procalcitonine (PCT) levels evolution

Time Frame: Up to 21 days

Procalcitonin (PCT) levels assessed daily up to 21 days

Secondary Outcomes

  • C-Reactive Protein (CRP)(Up to 21 days)
  • Biomarkers at day of Ventilator-Adquired Pneumonia (VAP)(Up to 21 days)

Study Sites (1)

Loading locations...

Similar Trials